Prati
Višnja Drinovac
Višnja Drinovac
Assistant-Research Associate, Department of Pharmacology, University of Zagreb Faculty of Pharmacy
Potvrđena adresa e-pošte na pharma.hr - Početna stranica
Naslov
Citirano
Citirano
Godina
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
Neuropharmacology 70, 331-337, 2013
672013
Association of antinociceptive action of botulinum toxin type A with GABA-A receptor
V Drinovac, L Bach-Rojecky, Z Lacković
Journal of neural transmission 121, 665-669, 2014
462014
Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region
V Drinovac Vlah, B Filipović, L Bach-Rojecky, Z Lacković
European Journal of Pain 22 (3), 583-591, 2018
392018
Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain
V Drinovac Vlah, L Bach-Rojecky, Z Lacković
Journal of Neural Transmission 123, 1403-1413, 2016
272016
Antinociceptive effect of botulinum toxin type A on experimental abdominal pain
V Drinovac, L Bach-Rojecky, A Babić, Z Lacković
European journal of pharmacology 745, 190-195, 2014
142014
What have we learned about antinociceptive effect of botulinum toxin type A from mirror-image pain models?
VD Vlah, L Bach-Rojecky
Toxicon 185, 164-173, 2020
62020
Mirror-Image Pain Update: Complex Interactions Between Central and Peripheral Mechanisms
V Drinovac Vlah, L Bach-Rojecky
Molecular Neurobiology, 1-18, 2024
2024
Botulinski toksin tip A-osnovni farmakološki profil i terapijska primena
L Bach-Rojecky, V Drinovac-Vlah
Arhiv za farmaciju 70 (1), 10-19, 2020
2020
Botulinum toxin and pain: Investigation of brain involvement
L Bach-Rojecky, VD Vlah, Z Lacković
Toxicon 156, S4-S5, 2018
2018
Menigeal Extravasation, Efficacy of Botulinum Toxin or Triptans are not specific for Pathophysiology of Migraine only (P4. 151)
Z Lackovic, I Matak, B Filipovic, V Drinovac-Vlah, LB Rojecky
Neurology 90 (15 Supplement), 2018
2018
Meningeal extravasation, efficacy of botulinum toxin or triptans is not specific for pathophysiology of migraine only
Z Lackovic, I Matak, B Filipovic, V Drinovac-Vlah, L Bach-Rojecky
Proceedings for Annual Meeting of The Japanese Pharmacological Society …, 2018
2018
Središnji neurotransmitori i mehanizam antinociceptivnog djelovanja botulinum toksina tipa A
V Drinovac Vlah
University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of …, 2017
2017
Role of capsaicin-sensitive neurons in bilateral antinociceptive effect of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
10th Forum of Neuroscience (FENS 2016), 2016
2016
Bilateral antinociceptive effect of botulinum toxin type A in a rat model of „mirror “pain involves spinal GABA
V Drinovac, L Bach-Rojecky, Z Lacković
9th Congress of the European Pain Federation EFIC, 2015
2015
136. Antinociceptive activity of botulinum toxin type A in the rat trigeminal region
I Matak, B Filipović, V Drinovac, L Bach-Rojecky, Z Lacković
Toxicon, S42, 2015
2015
SELECTIVE mu-OPIOID ANTAGONIST NALOXONAZINE REVERSES BILATERAL ANTINOCICEPTIVE EFFECT OF BOTULINUM TOXIN TYPE A IN A RAT MODEL OF" MIRROR" PAIN
V Drinovac, L Bach-Rojecky, Z Lackovic
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 212-213, 2014
2014
Selective mu-opioid receptor antagonist naloxonazine reverses bilateral antinociceptive effect of botulinum toxin type A in a rat model of" mirror" pain
V Drinovac, L Bach-Rojecky, Z Lacković
17th World Congress of Basic and Clinical Pharmacology, 212-212, 2014
2014
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–17